Health Care • Medical/Nursing Services
$1.67 ▲ +0.23
(+15.97%)
MKT CAP: $120.4M • VOL: 1.55M
52W L $1 52W H $11
AIRS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $151.8M | $180.3M | $195.9M |
| YoY Revenue Growth % | -15.8% | -7.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.6M | -$1.6M | $9.7M |
| Operating Margin % | -7.6% | -0.9% | 5.0% |
| Net Income (GAAP) | -$11.7M | -$8.0M | -$4.2M |
| EBITDA (Normalized) | -$9.6M | $9.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.1M | $11.3M | $24.0M |
| Capital Expenditures (CapEx) | $2.4M | $14.0M | — |
| Free Cash Flow (FCF) | $692.0K | -$2.7M | $24.0M |
| FCF Margin % | 0.5% | -1.5% | 12.2% |
| Return on Invested Capital (ROIC %) | -7.0% | -0.9% | — |
| Cash & Short-Term Equivalents | $8.4M | $8.2M | — |
| Total Debt (Short + Long Term) | $50.6M | $65.5M | — |
| Total Stockholders' Equity | $87.7M | $78.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AIRS.